CryoXtract Blog

Executive Spotlight: European Sales Manager Jay Champaneri

Posted by Graham Long on Dec 17, 2015 5:10:06 PM

 Jay Champaneri recently joined CryoXtract as Manager of European Sales. He is an accomplished professional with a significant track record of success within laboratory instrumentation in drug discovery and bioscience research. He brings particular expertise in the areas of cell biology, proteomics, genomics, imaging, and HTS/HCS.

Read More

Topics: Executive Spotlight

On the Conference Circuit: The National Biobank Symposium in Berlin

Posted by Jay Champaneri on Dec 11, 2015 7:46:51 AM
CryoXtract is excited to be appearing with distributor German-Cryo in Booth #14 of the 4th Annual Nationales Biobanken-Symposium 2015 in Berlin on December 9th and 10th. The event brings together biobanking professionals from all areas of the field to exchange information and ideas around key topics such as data management, sustainability, and best practices. 
Pictured below is Jay Champaneri of CryoXtract with German-Cryo Sales and Marketing Director Thomas Henne. Highlighted in the booth is the CryoXtract CXT 353 frozen sample aliquotter.
For more information, please visit the conference website at: 
Read More

Topics: biobanks, Conferences

On the Conference Circuit: BMB2015

Posted by Graham Long on Dec 10, 2015 4:39:15 PM
CryoXtract is pleased to be attending the Biochemistry and Molecular Biology (BMB2015) conference in Kobe, Japan with distributor, Asahi Life Science Co. The event is being held on Kobe Port Island and is expecting 6000 attendees, primarily researchers, in all aspects of Biochemistry & Molecular biology.
Read More

Topics: Conferences

In the Media: Scientists Call for National Microbiome Initiative

Posted by Amy Willson on Nov 23, 2015 10:49:27 AM

There is a strong belief among scientists that understanding microbial communities will lead to advances in environmental protection and human health. In recent articles published in Science and Nature and summarized by The New York Times here, researchers called for government support of a national microbiome initiative to study microbial communities. Such an initiative could lead to better understanding of the role of the microbiome in disease progression and prevention, as well as offer further opportunities to investigate the potential of microbiome manipulations such as fecal transplantations.

Read More

Topics: Microbiome

In the Media: Gut Microbiome and HIV Vaccines

Posted by Joe Fraone on Oct 23, 2015 1:45:42 PM

In a recent article in Hutch News, found here, the gut microbiome was shown to have a negative effect on the success of HIV vaccines. The recent HIV vaccine tested boosted production of antibodies that bind both the HIV virus and several intestinal bacteria. Researchers suspect that the HIV virus mimics common gut microbia that are not targeted by the immune system. Future vaccine trials will involve infants with undeveloped immune systems, hoping to circumvent the protective effects of the gut microbiome. In addition, future vaccine trials will incorporate gut microbiome analysis to further understand the link between vaccine effectiveness and the microbiome.

Read More

Topics: Microbiome, Gut Microbiome

On the Conference Circuit: Booth #7 at Global Engage Microbiome US

Posted by Joe Fraone on Sep 11, 2015 10:56:04 AM

CryoXtract is excited to participate in this year's Global Engage Microbiome R&D and Business Collaboration Forum in San Diego. The event on September 10th and 11th brings together over 200 industry leaders for engaging panel discussions, presentations and exhibition. Key topics include highlights of new microbiome research, discussions of venture and other capital investment in the field, and more.

Read More

Topics: Conferences, Gut Microbiome

In the Media: Investigations in Interactions Between Gut Microbiota and Berberine

Posted by Joe Fraone on Sep 4, 2015 7:41:33 PM

A July, 2015 publication of a study in Scientific Reports found here investigates the interactions between gut microbiota and berberine, a dietary supplement used for the treatment of lipid- and glucose-related disorders.  In the study, researchers found that gut microbiota reduced berberine to an absorbable form in the intestine, increasing its effectiveness.  The authors conclude that there can be critical interaction between intestinal bacteria and orally-administered drugs and suggest that the effect of gut microbiota on orally-administered drug metabolism should be investigated during drug development.

Read More

Topics: Press Summaries, Gut Microbiome

In the Media: The Next Frontier of Biobanking

Posted by Joe Fraone on Aug 19, 2015 2:38:22 PM

A recent article in Genetic Engineering and Biotech News, found here, discusses the necessity of and options for improved biospecimen tracking, procurement, and distribution that extends beyond biobanks alone. The authors emphasize the importance of rich analytical biospecimen data, dynamic sample collection, and efficient sample distribution. With the ultimate goal to propel biobanking forward in order to efficiently support the advancement of personalized medicine, frozen aliquotting technology’s ability to preserve biospecimen integrity and increase utilization is key to this goal.

Read More

Topics: biobanks, biobanking, personalized medicine

In the Media: Failures in Incurred Sample Reanalysis

Posted by Joe Fraone on Aug 4, 2015 5:22:00 PM

Failures in incurred sample reanalysis (ISR) can be very problematic to life science researchers working in drug discovery and regulated bioanalysis. As a tool for confirming reliability of bioanalytical measurements, concerns with and failures of ISR can significantly delay drug development and can be very costly to remedy. An article in AAPS earlier this year (found here) discusses difficulties with ISR imprecision particularly in small molecule studies. 

Read More

Topics: biospecimens, Press Summaries

In the Media: Integrated Data and Personalized Medicine

Posted by Joe Fraone on Jul 20, 2015 10:44:49 AM

Integrating data from tissue imaging, genomic databases, and clinical results could be a major key in the journey toward truly personalized medicine, according to a recent article in Genetic Engineering and Biotechnology News (found here). Careful maintenance of patient data correlated with tissue samples is one element of the best practices necessary for a truly integrated data approach to drug discovery and development.

Read More

Topics: biobanking, Press Summaries, data